Immunological Equivalence Between GSK2340272A and GSK2340274A Influenza Vaccines in Adults Aged 18 to 60 Years.
Phase of Trial: Phase III
Latest Information Update: 14 Aug 2018
At a glance
- Drugs Influenza A virus vaccine-H1N1 (Primary)
- Indications Influenza A virus H1N1 subtype
- Focus Pharmacodynamics; Registrational
- Sponsors GlaxoSmithKline
- 24 Mar 2012 This trial is recruiting in France.
- 03 Dec 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 31 Oct 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.